http://www.zibb.com/all/theme/cq/MedMira+Incorporated Zibb. The Global business search engine. en-US search@zibb.com (RB Search)Copyright (c) 2007 Reed Business Information. All rights reserved.Mon, 23 Nov 2009 17:13:39 GMTMon, 23 Nov 2009 17:13:39 GMT608831http://www.zibb.com/all/theme/cq/MedMira+Incorporated http://www.zibb.com/images/en/g_zibb_logo_beta.gif http://www.cheviotartus.co.uk/pre_employment_questionnaires/pre_employment_questionnaires_478.htmlAcquires SensorChem to Expand World Class Diagnostic Product Line HALIFAX, Dec. 15 /PRNewswire-FirstCall/ - MedMira Inc., ("MedMira") (TSX Venture: MIR, NASDAQ: MMIRF) the global market leader in premium rapid diagnostic solutions, announced today that it has acquired SensorChem International Corp.http://www.cheviotartus.co.uk/pre_employment_questionnaires/pre_employment_questionnaires_478.htmlMedMira Incorporatedhttp://www.foodservicecentral.com/storefronts/americanhealthdiagnostics.htmlAHD is the exclusive US distributor for MedMira Laboratories Inc., a Canadian biotechnology company. Our products currently include rapid diagnostic test kits for laboratories, physician offices, hospitals and clinics.http://www.foodservicecentral.com/storefronts/americanhealthdiagnostics.htmlMedMira Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=411952006 NOV 15 - (NewsRx.com) -- MedMira Inc. (MIR), a developer of rapid diagnostic solutions, announced that it has received United States Food and Drug Administration (FDA) approval for its Reveal G3 Rapid HIV-1 antibody test (Reveal G3).http://www.pharmacychoice.com/News/article.cfm?Article_ID=41195MedMira Incorporatedhttp://www.ishareowner.com/csr/profile.cgi?id=7299Home | News | Reports | Marketplace | About Us | Contact | Tools | Login Corporate Social Research | Mutual Funds | Shareowner Action | Community Investment © SRI World Group, Inc.http://www.ishareowner.com/csr/profile.cgi?id=7299MedMira Incorporatedhttp://www.cnw.ca/langLink.cgi?lang=0&url=/en/releases/archive/December2006/05/c3797.htmlMedMira's first quarter financial results were released on November 28, 2006 and are available on the MedMira website at www.medmira.com. In order to listen to the conference call, please dial 1-800-814-4861 toll-free anywhere in Canada or the USA, or 1-416-644-3417 in the Toronto area.http://www.cnw.ca/langLink.cgi?lang=0&url=/en/releases/archive/December2006/05/c3797.htmlMedMira Incorporatedhttp://www.publichealthlab.com/dev1/reports.php?page=6An Outbreak of Salmonella Enteritidis Squires S., Roberts A., Stratton F., Ratnam S., Khakhria R., Ellis A., Kamanzi J., Johnson W., and Hockin J. No free lunch: an outbreak of Salmonella enteritidis. Abstr. International Clin. Epidemiol. Network, Bangkok. 1998.http://www.publichealthlab.com/dev1/reports.php?page=6MedMira Incorporatedhttp://www.hivandhepatitis.com/recent/test/antibody/041803t.htmlFDA Clears HIV Test That Gives Results in 3 Minutes By Ori Twersky Canada's MedMira Inc. said on Thursday that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its 3-minute Reveal Rapid HIV-1 Antibody test. Rival firm OraSure Technologies Inc.http://www.hivandhepatitis.com/recent/test/antibody/041803t.htmlMedMira Incorporatedhttp://www.micromedex.com/pressroom/news_feeds/?story_ID=37100&category=19Get the news that matters to you. Create your own customized news service that delivers the latest information directly to you. Plus you can view the most current press releases from Micromedex.http://www.micromedex.com/pressroom/news_feeds/?story_ID=37100&category=19MedMira Incorporatedhttp://www.newswire.ca/en/releases/archive/December2006/20/c9228.htmlMedMira has received an initial order from INyDIA for the MiraCare(TM) Rapid HIV Antibody Test (MiraCare HIV), which will be shipped in early 2007.http://www.newswire.ca/en/releases/archive/December2006/20/c9228.htmlMedMira Incorporatedhttp://www.canadait.com/cfm/index.cfm?It=106&Id=26364&Se=2&Sv=&Lo=2Under the terms of the agreement, the debenture will bear interest of 10% per annum and be subject to a one-time fee of 5.5% of the debenture amount. The debenture is convertible in whole or in part into common shares of MedMira at $.http://www.canadait.com/cfm/index.cfm?It=106&Id=26364&Se=2&Sv=&Lo=2MedMira Incorporatedhttp://www.cheviotartus.co.uk/pre_employment_questionnaires/pre_employment_questionnaires_494.htmlm. Eastern Standard Time (10:00 a.m. Atlantic) on Tuesday, December 20, 2005. The call will be preceded by the release of the companys first quarter financial results the previous evening and they will be available on the MedMira web site http://www.medmira.http://www.cheviotartus.co.uk/pre_employment_questionnaires/pre_employment_questionnaires_494.htmlMedMira Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=24633MedMira's comprehensive OTC system is all-inclusive, containing everything necessary to obtain definitive test results and support the consumer, with confidential counselling and medical referrals.http://www.pharmacychoice.com/News/article.cfm?Article_ID=24633MedMira Incorporatedhttp://www.ishareowner.com/news/release.cgi?sfArticleId=2959These rapid HIV tests enabled the medical clinic at the orphanage to screen each child residing at the site for HIV-infection (the virus that causes AIDS) and provide subsequent counseling and care.http://www.ishareowner.com/news/release.cgi?sfArticleId=2959MedMira Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=8131MedMira along with its distributors in these regions, Genesis and Exportrade, have been working hard to complete the rigorous medical device registration process for its rapid flow-through diagnostic tests in these three Latin American countries.http://www.pharmacychoice.com/News/article.cfm?Article_ID=8131MedMira Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=27715for its MiraWell(R) Rapid HIV Test (MiraWell HIV) for use with whole blood specimens. MedMira's test is the first and only whole blood rapid HIV test to fulfill the rigorous clinical requirements of the Chinese regulatory body.http://www.pharmacychoice.com/News/article.cfm?Article_ID=27715MedMira Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=39223Food and Drug Administration (FDA) approval for its Reveal(R) G3 Rapid HIV-1 Antibody Test (Reveal G3). Reveal G3, which delivers test results in less than three minutes, is the third generation in the Reveal line of rapid HIV tests.http://www.pharmacychoice.com/News/article.cfm?Article_ID=39223MedMira Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=10703HALIFAX, Nova Scotia_MedMira Inc. has begun a partnership with Chinese pharmaceutical firm Tianhe Pharmaceutical Co. Ltd. it says will open new over-the-counter markets in China for its rapid diagnostic products.http://www.pharmacychoice.com/News/article.cfm?Article_ID=10703MedMira Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=42267/CNW/ - MedMira Inc., ("MedMira") (TSX Venture: MIR, NASDAQ: MMIRF) a global market leader in premium rapid diagnostic solutions, announced today that it has signed an exclusive distribution agreement with Italian distributor Voden Medical Instruments spa (Voden).http://www.pharmacychoice.com/News/article.cfm?Article_ID=42267MedMira Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=18822/CNW/ - MedMira Inc., ("MedMira") (TSX Venture: MIR, NASDAQ: MMIRF) the global market leader in premium rapid diagnostic solutions, announced today that it has received an order for 60,000 MiraCare(TM) Rapid HIV Tests (MiraCare(TM)) from its distributor, Goodman Medical Supplies Ltd. (Goodman).http://www.pharmacychoice.com/News/article.cfm?Article_ID=18822MedMira Incorporatedhttp://www.cnw.ca/en/releases/orgDisplay.cgi?okey=16786CNW Telbec HOME / FRANÇAIS / SITE MAP / ABOUT CNW TELBEC / CONTACT US / SERVICES OFFERED / LOGIN December 11, 2006 QUICK SEARCH BY ORGANIZATION OTHER SEARCH OPTIONS HOT TOPICS Company Earnings NEWS & INFORMATION: News Releases Webcasts/Podcasts Photos Multimedia News Releases Media Daybook Earningshttp://www.cnw.ca/en/releases/orgDisplay.cgi?okey=16786MedMira Incorporatedhttp://www.cnw.ca/en/releases/orgDisplay.cgi?okey=16786&pos=30CNW Telbec HOME / FRANÇAIS / SITE MAP / ABOUT CNW TELBEC / CONTACT US / SERVICES OFFERED / LOGIN December 31, 2006 QUICK SEARCH BY ORGANIZATION OTHER SEARCH OPTIONS HOT TOPICS company earnings NEWS & INFORMATION: News Releases Webcasts/Podcasts Photos Multimedia News Releases Media Daybook Earningshttp://www.cnw.ca/en/releases/orgDisplay.cgi?okey=16786&pos=30MedMira Incorporatedhttp://www.cnw.ca/en/releases/orgDisplay.cgi?okey=16786&view=printMEDMIRA INC. NEWS RELEASES FOUND: 124 PAGE 1 of 13 | 1 2 3 4 5 6 7 8 [Next] [Last] December 20, 2006 MedMira Widens European Sales Network with Distribution Partner for Spain, Portugal and France 10:09 ET December 5, 2006 MedMira Invites Investment Analysts to Conference Call 12:28 ET November 28,http://www.cnw.ca/en/releases/orgDisplay.cgi?okey=16786&view=printMedMira Incorporatedhttp://www.cnw.ca/en/releases/archive/September2006/05/c2758.htmlHALIFAX, NS, Sept. 5 /CNW/ - MedMira Inc., ("MedMira") (TSX Venture: MIR, NASDAQ: MMIRF) a global market leader in premium rapid diagnostic solutions, announced today that it has completed product shipments to Argentina and Colombia.http://www.cnw.ca/en/releases/archive/September2006/05/c2758.htmlMedMira Incorporatedhttp://www.cnw.ca/en/releases/archive/September2006/20/c3378.htmlHALIFAX, Sept. 20 /CNW/ - MedMira Inc., ("MedMira") (TSX Venture: MIR, NASDAQ: MMIRF) the global market leader in premium rapid diagnostic solutions, announced today that it has submitted a draw down notice for $28,000 to Cornell Capital Partners, LP ("Cornell") against its equity line of credit.http://www.cnw.ca/en/releases/archive/September2006/20/c3378.htmlMedMira Incorporatedhttp://www.cnw.ca/en/releases/archive/September2006/29/c3505.htmlHALIFAX, Sept. 29 /CNW/ - MedMira Inc. ("MedMira") (TSX Venture: MIR, NASDAQ:MMIRF) a global market leader in premium rapid diagnostic solutions, today announced its financial results for the three month and year end periods ending July 31, 2006.http://www.cnw.ca/en/releases/archive/September2006/29/c3505.htmlMedMira Incorporated